Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial

[1] Alla F(2007)Epidemiology of acute heart failure syndromes Heart Fail Rev 12 91-95

[2] Zannad F(2010)Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure 1993–2006 JAMA 303 2141-2147

[3] Filippatos G(2015)Recommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine Eur J Heart Fail 17 544-558

[4] Bueno H(2015)Sex differences in new-onset heart failure Clin Res Cardiol 104 342-350

[5] Ross JS(2015)Gender differences in clinical characteristics and outcome of acute heart failure in sub-Saharan Africa: results of the THESUS-HF study Clin Res Cardiol 104 481-490

[6] Wang Y(2015)Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation Eur J Heart Fail 17 570-582

[7] Chen J(2008)Management of atrial fibrillation in patients with heart failure J Card Fail 14 232-237

[8] Vidan MT(2013)Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure) JACC Heart Fail 1 192-199

[9] Normand SL(2009)Determinants of plasma NT-pro-BNP levels in patients with atrial fibrillation and preserved left ventricular ejection fraction Clin Res Cardiol 98 101-106

[10] Curtis JP(2014)AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society Circulation 130 2071-2104

[1] Alla F(2007)Epidemiology of acute heart failure syndromes Heart Fail Rev 12 91-95

[2] Zannad F(2010)Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure 1993–2006 JAMA 303 2141-2147

[3] Filippatos G(2015)Recommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine Eur J Heart Fail 17 544-558

[4] Bueno H(2015)Sex differences in new-onset heart failure Clin Res Cardiol 104 342-350

[5] Ross JS(2015)Gender differences in clinical characteristics and outcome of acute heart failure in sub-Saharan Africa: results of the THESUS-HF study Clin Res Cardiol 104 481-490

[6] Wang Y(2015)Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation Eur J Heart Fail 17 570-582

[7] Chen J(2008)Management of atrial fibrillation in patients with heart failure J Card Fail 14 232-237

[8] Vidan MT(2013)Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure) JACC Heart Fail 1 192-199

[9] Normand SL(2009)Determinants of plasma NT-pro-BNP levels in patients with atrial fibrillation and preserved left ventricular ejection fraction Clin Res Cardiol 98 101-106

[10] Curtis JP(2014)AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society Circulation 130 2071-2104